Periodontal Disease Treatment Market: Growth, Size, Share, and Trends

Report Code MD 9220
Published in Nov, 2024, By MarketsandMarkets™
Download PDF

Choose License Type

Buy Report Now Inquire Before Buying

Periodontal Disease Treatment Market by Product (Equipment, Consumables), Disease (Gingivitis, Periodontitis), Treatment (Bone Grafting, Scaling, Flap Surgery, Regeneration), End User (Clinics, Private DSOs), and Region - Global Forecast to 2030

Overview

The global periodontal disease treatment market, valued at US$2.44 billion in 2023, is forecasted to grow at a robust CAGR of 5.9%, reaching US$2.58 billion in 2024 and an impressive US$3.63 billion by 2030. Growth in this market is mainly driven by the increasing number of dental clinics and dedicated periodontal care centers and the increased reimbursement policies. Rising healthcare costs, particularly in developing countries, will also positively impact the demand for periodontal treatment. The increased trend of cosmetic dentistry, which promotes periodontal health for esthetic purposes, further advances the market.

However, high treatment costs and limited access to advanced treatments in underdeveloped regions may hinder market growth to some extent.

Attractive Opportunities in the Periodontal Disease Treatment Market

Asia Pacific

Market growth in Asia Pacific can be attributed to the rising prevalence of dental disorders and the large patient pool.

Growth in the global market can be attributed to the increased demand for minimally invasive dental surgeries and the rising prevalence of oral health disorders.

The increasing competition in the dental industry and the high-growth potential of emerging markets are likely to promote significant growth opportunities for market players.

The Asia Pacific dominates the periodontal disease treatment market. This market is projected to reach USD 0.85 billion by 2030, at a CAGR of 6.9% during the forecast period.

Europe is the second-largest regional market for periodontal disease treatment due to increasing investments by key players in the region.

Global Periodontal Disease Treatment Market Dynamics

DRIVER: Increasing incidence of oral health disorders

The rising incidence of oral health disorders is a major factor driving the growth of the periodontal disease treatment market. Oral diseases affect nearly 3.5 billion people worldwide, and the most common conditions include periodontal disease, as reported by the World Health Organization (WHO). In the US, the CDC states that nearly 47% of adults aged 30 and over suffer from some form of periodontal disease; this prevalence increases by up to 70% among those aged 65 and older.

Rising cases of these diseases can be attributed to related factors such as poor oral hygiene, unhealthy dietary habits, and the rising intake of tobacco and alcohol, which are major risk factors for gum diseases. The emerging incidence of diabetes, which is closely related to periodontal disease, also fuels the growth of the market. According to the International Diabetes Federation, it is estimated that around 537 million adults are projected to be suffering from diabetes all over the world in 2021, and this number is expected to reach up to 643 million by 2030. This will create additional opportunities for players in the periodontal disease treatment market.

Increased oral health disorders call for early diagnosis and proper treatments, thereby facilitating the growth of the market for periodontal disease treatments.

RESTRAINT: High cost of advanced periodontal treatments

Periodontal disease treatments, such as surgeries, laser procedures, and other regenerative treatments, are costly. These procedures are too expensive, especially for low- and middle-income countries where out-of-pocket health spending is proportionately much higher. The World Bank estimates that out-of-pocket financing contributes more than 60% to the health expenditure of many low- and middle-income countries, making these treatments unaffordable to a significant population.

The highly technical periodontal surgical procedure could run into several thousands of dollars per quadrant, up to USD 1,000 to USD 3,000 in developed nations. Laser treatments for gum infections may range between USD 1,000 to USD 2,500 per session as a result of the condition's severity.

 

OPPORTUNITY: Increasing number of DSOs in dental industry

There is a significant opportunity for periodontal treatment services from DSOs, which contribute to advancements in the industry. DSOs combine dental practices into a single company, which further amalgamates the activities while ensuring better care for patients by generating economies of scale.

The American Dental Association projects that by 2025, DSOs will capture 20% of the dental market share, up from the 10% captured in 2020. This growth allows for investing in more advanced periodontal treatment technologies and further access to specialist care. At the same time, as DSOs focus on preventive care, they automatically contribute to the early detection and management of periodontal diseases, further reducing the overall treatment burden. The Journal of Periodontology reports a 15% increase in the use of evidence-based periodontal treatment protocols by DSOs, which is crucial for improving patient treatment outcomes. By combining dental care services into DSOs, operations are enhanced, and a wider range of patients can be served. This trend is driving the demand for periodontal disease treatments in a growing market.

 

CHALLENGES: Lack of skilled professionals

A major challenge in treating periodontal disease is the shortage of trained dental professionals. According to the World Health Organization, there is an estimated global deficit of 1.5 million oral health professionals, with the Third World particularly affected by this. In India, the Indian Dental Association reports that although there are more than 300 dental colleges, only a small number of graduates specialize in periodontology. This scarcity of specialists results in limited access to periodontal care, especially in rural areas where dental services are often lacking.

A report in the Journal of Periodontology indicated that nearly 70% of periodontal patients do not receive timely recommended treatment due to the shortage of qualified professionals. Additionally, the underdeveloped training programs at dental schools worsen the situation, hindering the workforce's ability to address the increasing prevalence of periodontal disease. This shortage significantly affects the success of patient treatment and the overall growth of the market for periodontal disease treatment, as effective care largely depends on the availability of trained professionals.

Global Periodontal Disease Treatment Market Ecosystem Analysis

The ecosystem of the periodontal disease treatment market comprises elements present in this market, and these elements are defined with a demonstration of the bodies involved. It includes manufacturers, distributors, research & product developers, and end users. The ecosystem of the overall periodontal disease treatment market comprises the different elements and subdivisions present in it. Manufacturers include the organizations involved in the entire process of research, product development, optimization, and launch. Distributors include third parties and eCommerce sites, which are linked with organizations for marketing.

 

By disease type, the aggressive periodontitis segment is the fastest-growing segment in the periodontal disease treatment market during the forecast period.

Based on disease type, the aggressive periodontitis segment is the fastest-growing segment in the periodontal disease treatment market. Aggressive periodontitis is emerging as a significant area of growth in the treatment of periodontal disease. The increasing prevalence of this condition, along with the urgent need for effective management strategies, is driving this growth. This form of periodontal disease is characterized by rapid loss of attachment and destruction of bone mass, often affecting young adolescents and young adults.

Recent studies published in the Journal of Clinical Periodontology indicate that the prevalence of aggressive periodontitis is approximately 1% to 2% of the global population. An increased incidence of this condition is observed in urban areas, largely due to lifestyle factors, inadequate oral hygiene, and dietary habits.

By end user, hospitals hold the largest share of the periodontal disease treatment market.

The periodontal disease treatment market has been classified by end users into hospitals, DSOs, independent clinics, and academic & research institutions. In 2023, hospitals dominated the market.

Hospitals hold the largest share of the periodontal disease treatment market. As awareness of oral health improves and lifestyle changes are implemented, there has been an increase in the cases of periodontal disease, leading to more patients seeking treatment in healthcare facilities. It is reported that periodontal disease affects 45% of adults aged 30 and older, highlighting the significant demand for treatment in hospitals. With advanced technologies and specialized dental units, comprehensive periodontal care is becoming a central focus in these facilities. Additionally, the inclusion of a multidisciplinary team—consisting of periodontists, dental hygienists, and general practitioners—allows for the development of effective treatment plans.

Asia Pacific segment is the fastest growing segment in the Periodontal disease treatment market in 2023

The Asia Pacific region is the fastest-growing market for periodontal disease treatment. This growth is driven by an increasing population, particularly in countries like India and China, alongside shifts in lifestyles and diets that have led to a rise in the diagnosis of periodontal diseases. The availability of improved dental facilities, combined with government initiatives promoting good oral health, will further enhance market demand.

Additionally, the growth of middle-class families with higher disposable incomes is making more people willing to invest in dental care. The entry of international manufacturers and the adoption of modern treatment technologies are also evolving the market landscape. As a result, the Asia Pacific region is emerging as a competitive leader in the global periodontal disease treatment market.

HIGHEST CAGR MARKET IN 2023
ASIA_PACIFIC FASTEST GROWING MARKET IN THE REGION

Recent Developments of Periodontal Disease Treatment Market

  • In May 2024, Dentsply Sirona launched a medical-grade 3D printing solution integrated with end-to-end workflow offerings for dental practices and labs in collaboration with Google LLC.
  • In September 2023, J. Morita Corp. launched its new Veraview X800 3D CBCT imaging system. This system is designed to provide dentists with high-quality 3D images of patients’ teeth and jaws.
  • In April 2023, Henry Schein acquired a majority ownership position in Biotech Dental, aiming to create a digital workflow that provides a seamless journey for customers to increase case acceptance and improve clinical outcomes for practitioners
  • In January 2023, eAssist Dental Solutions (eAssist), a Henry Schein subsidiary, acquired a majority interest in Unitas PPO Solutions (Unitas) to improve fee analysis services offered by Henry Schein and enhance the collection processes of the eAssist platform.

Key Market Players

Want to explore hidden markets that can drive new revenue in Periodontal Disease Treatment Market?

Scope of the Report

Report Metric Details
Market size available for years 2024-2030
Base Year Considered 2023
Forecast period 2024-2030
Forecast units Value (USD)
Segments covered Product Type, Method, Application, and End User
Geographies covered North America, Europe, Asia Pacific, Latin America, and the Middle East and Africa

 

Key Questions Addressed by the Report

What are the drivers of the periodontal disease treatment market?
The market is driven by technological advancements, the rising prevalence of oral health disorders, and the growing demand for cosmetic dental procedures.
Which disease type segment dominates the periodontal disease treatment market?
The gingivitis segment dominates the periodontal disease treatment market.
Who are the end users of periodontal disease treatment products? Which end user is leading the market?
The end users include hospitals, DSOs, academic & research institutions, and independent clinics. In 2023, hospitals accounted for the largest market share.
Who are the key players in the periodontal disease treatment market?
The key players include Dentsply Sirona Inc., Envista Holdings Corporation, A-dec Inc., J. Morita Corp., Straumann Group, BIOLASE, BEGO GmbH & Co. KG, Ultradent Products, Yoshida Dental, and Nakanishi Inc.
Which region is the most lucrative in the periodontal disease treatment market?
The Asia Pacific region is expected to witness the highest growth during the forecast period.

 

Personalize This Research

  • Triangulate with your Own Data
  • Get Data as per your Format and Definition
  • Gain a Deeper Dive on a Specific Application, Geography, Customer or Competitor
  • Any level of Personalization
Request A Free Customisation

Let Us Help You

  • What are the Known and Unknown Adjacencies Impacting the Periodontal Disease Treatment Market
  • What will your New Revenue Sources be?
  • Who will be your Top Customer; what will make them switch?
  • Defend your Market Share or Win Competitors
  • Get a Scorecard for Target Partners
Customized Workshop Request

Table of Contents

Exclusive indicates content/data unique to MarketsandMarkets and not available with any competitors.

TITLE
PAGE NO
INTRODUCTION
27
RESEARCH METHODOLOGY
31
EXECUTIVE SUMMARY
45
PREMIUM INSIGHTS
49
MARKET OVERVIEW
52
  • 5.1 INTRODUCTION
  • 5.2 MARKET DYNAMICS
    DRIVERS
    - Increasing prevalence of oral disorders
    - Rising cases of edentulism
    - Emergence of innovative dental treatment procedures
    - Expanding market for dental tourism in emerging economies
    RESTRAINTS
    - High cost of advanced treatments and inadequate reimbursements for dental procedures
    OPPORTUNITIES
    - Impact of DSOs on dental industry
    - Growing awareness about oral health
    CHALLENGES
    - Shortage of skilled dental practitioners
  • 5.3 INDUSTRY TRENDS
    INCREASING PREFERENCE OF MINIMALLY INVASIVE DENTAL PROCEDURES
    MARKET CONSOLIDATION
    DENTAL INSURANCE IN US
  • 5.4 TECHNOLOGY ANALYSIS
    KEY TECHNOLOGIES
    - 3D printers
    - Artificial intelligence
    ADJACENT TECHNOLOGIES
    - Virtual reality
    - Laser dentistry
  • 5.5 VALUE CHAIN ANALYSIS
  • 5.6 ECOSYSTEM MAP
  • 5.7 SUPPLY CHAIN ANALYSIS
  • 5.8 REGULATORY ANALYSIS
    REGULATORY LANDSCAPE
    - US
    - EU
    - China
    REGULATORY BODIES, GOVERNMENT AGENCIES, AND OTHER ORGANIZATIONS
  • 5.9 PATENT ANALYSIS
    PATENT PUBLICATION TRENDS FOR PERIODONTAL DISEASE TREATMENT
    INSIGHTS: JURISDICTION AND TOP APPLICANT ANALYSIS
  • 5.10 TRADE ANALYSIS
  • 5.11 TRENDS/DISRUPTIONS IMPACTING CUSTOMERS’ BUSINESSES
  • 5.12 ADJACENT MARKETS FOR PERIODONTAL DISEASE TREATMENT
  • 5.13 CASE STUDY ANALYSIS
    CASE STUDY 1: INNOVATION TRACKING, TECHNOLOGY ASSESSMENT, AND PRODUCT LAUNCHES IN ANTIMICROBIAL AGENTS & COATING SUBSTANCES FOR DENTAL IMPLANTS
    CASE STUDY 2: CUSTOMIZED STUDY FOR MEA
    CASE STUDY 3: CUSTOMIZED STUDY FOR LATIN AMERICA
  • 5.14 PORTER’S FIVE FORCES ANALYSIS
    THREAT OF NEW ENTRANTS
    THREAT OF SUBSTITUTES
    BARGAINING POWER OF SUPPLIERS
    BARGAINING POWER OF BUYERS
    INTENSITY OF COMPETITIVE RIVALRY
  • 5.15 KEY CONFERENCES & EVENTS, 2024
  • 5.16 PRICING ANALYSIS
    AVERAGE COST OF PERIODONTAL DISEASE TREATMENT SYSTEMS (2021−2023) (USD)
    AVERAGE COST RANGE OF PERIODONTAL DISEASE TREATMENT, BY REGION (2021−2023) (USD)
    AVERAGE SELLING PRICE OF PERIODONTAL DISEASE TREATMENT, BY PRODUCT TYPE
  • 5.17 KEY STAKEHOLDERS AND BUYING CRITERIA
    KEY STAKEHOLDERS IN BUYING PROCESS
    BUYING CRITERIA
  • 5.18 UNMET NEEDS IN PERIODONTAL DISEASE TREATMENT MARKET
  • 5.19 INVESTMENT & FUNDING SCENARIO
  • 5.20 PREVALENCE OF GINGIVAL CASES IN KEY COUNTRIES
  • 5.21 ANALYSIS OF TOTAL NUMBER OF SURGERIES IN KEY COUNTRIES
PERIODONTAL DISEASE TREATMENT MARKET, BY PRODUCT
86
  • 6.1 INTRODUCTION
  • 6.2 EQUIPMENT
    GROWING PREFERENCE FOR MIS PROCEDURES TO DRIVE MARKET
  • 6.3 CONSUMABLES
    RECURRING NATURE & FREQUENT PURCHASE TO PROPEL MARKET
  • 6.4 MEDICATION
    GROWING AWARENESS OF ORAL HEALTH AND IMPROVEMENTS IN ANTIBIOTICS TO SUPPORT MARKET
PERIODONTAL DISEASE TREATMENT MARKET, BY DISEASE
92
  • 7.1 INTRODUCTION
  • 7.2 GINGIVITIS
    ACUTE GINGIVITIS
    - Prevalence in children and adolescents to drive market
    RECURRENT GINGIVITIS
    - Recurrent cases of bacterial infection due to poor oral hygiene to fuel market
    CHRONIC GINGIVITIS
    - Prolonged inflammation of gums to support market growth
  • 7.3 CHRONIC PERIODONTITIS
    INCREASING CASES OF EDENTULISM TO FUEL MARKET
  • 7.4 AGGRESSIVE PERIODONTITIS
    RAPID TOOTH LOSS AND UNDERLYING HEALTH CONDITIONS TO CONTRIBUTE TO MARKET GROWTH
  • 7.5 OTHER DISEASES
PERIODONTAL DISEASE TREATMENT MARKET, BY TREATMENT
103
  • 8.1 INTRODUCTION
  • 8.2 NON-SURGICAL TREATMENT
    SCALING
    - Ability to inhibit bacterial infection to fuel uptake
    ROOT PLANING
    - Reduction of gingival pockets to support market growth
    MEDICATION THERAPY
    - Topical therapy
    - Systemic therapy
  • 8.3 FLAP SURGERY/POCKET REDUCTION THERAPY
    COMMON SURGICAL PROCEDURE FOR ADVANCED PERIODONTAL DISEASES TO DRIVE MARKET
  • 8.4 SOFT TISSUE GRAFT
    PREVALENCE OF GINGIVAL RECESSION TO FUEL UPTAKE
  • 8.5 BONE GRAFTING
    GROWING FOCUS ON REGENERATION OF BONES TO FUEL UPTAKE
  • 8.6 GUIDED TISSUE REGENERATION
    HIGH SUCCESS RATE TO PROPEL MARKET
  • 8.7 OTHER TREATMENTS
PERIODONTAL DISEASE TREATMENT MARKET, BY END USER
119
  • 9.1 INTRODUCTION
  • 9.2 HOSPITALS
    AVAILABILITY OF ADVANCED EQUIPMENT FOR DENTISTRY AND GROWING FOCUS ON DENTAL TOURISM TO PROPEL MARKET
  • 9.3 PRIVATE & DSO CLINICS
    INCREASING ESTABLISHMENT OF PRIVATE PRACTICES TO DRIVE MARKET
  • 9.4 ACADEMIC & RESEARCH INSTITUTES
    R&D FUNDING INITIATIVES TO SUPPORT MARKET GROWTH
PERIODONTAL DISEASE TREATMENT MARKET, BY REGION
126
  • 10.1 INTRODUCTION
  • 10.2 NORTH AMERICA
    NORTH AMERICA: MACROECONOMIC OUTLOOK
    US
    - Favorable reimbursement policies for dental procedures to drive market
    CANADA
    - Rising incidence of dental caries to drive market
  • 10.3 EUROPE
    EUROPE: MACROECONOMIC OUTLOOK
    GERMANY
    - Hub for advanced dentistry technologies to propel market
    FRANCE
    - Favorable government healthcare policies to fuel uptake
    UK
    - Increasing incidence of dental disorders to drive market
    ITALY
    - Low-cost dental treatments to support market growth
    SPAIN
    - Privatization of dental clinics and uptake of advanced technologies to support market growth
    REST OF EUROPE
  • 10.4 ASIA PACIFIC
    ASIA PACIFIC: MACROECONOMIC OUTLOOK
    CHINA
    - Growing prevalence of dental diseases to drive market growth in China
    JAPAN
    - Rising geriatric population and favorable reimbursement scenario to support market growth
    INDIA
    - Expansion of dentistry and growing awareness of oral hygiene to drive market
    AUSTRALIA
    - Favorable government initiatives and growing prevalence of dental diseases to drive market
    SOUTH KOREA
    - Increasing cases of edentulism to fuel uptake
    REST OF ASIA PACIFIC
  • 10.5 LATIN AMERICA
    LATIN AMERICA: MACROECONOMIC OUTLOOK
    MEXICO
    - Growth in dental tourism to drive market
    BRAZIL
    - Trend of cosmetic dentistry to propel market
    ARGENTINA
    - increasing use of CAD/CAM systems to support market growth
    REST OF LATIN AMERICA
  • 10.6 MIDDLE EAST & AFRICA
    RISING AWARENESS ABOUT DENTAL HYGIENE TO SUPPORT MARKET GROWTH
    MIDDLE EAST & AFRICA: MACROECONOMIC OUTLOOK
  • 10.7 GCC COUNTRIES
    GROWING DEMAND FOR PERSONALIZED DENTISTRY TO DRIVE MARKET
    GCC COUNTRIES: MACROECONOMIC OUTLOOK
COMPETITIVE LANDSCAPE
207
  • 11.1 INTRODUCTION
  • 11.2 KEY PLAYER STRATEGY/RIGHT TO WIN
    OVERVIEW OF STRATEGIES ADOPTED BY KEY PLAYERS IN PERIODONTAL DISEASE TREATMENT MARKET
  • 11.3 REVENUE ANALYSIS, 2019−2023
  • 11.4 MARKET SHARE ANALYSIS, 2023
  • 11.5 COMPANY EVALUATION MATRIX: KEY PLAYERS, 2023
    STARS
    EMERGING LEADERS
    PERVASIVE PLAYERS
    PARTICIPANTS
    COMPANY FOOTPRINT: KEY PLAYERS, 2023
    - Company footprint
    - Region footprint
    - Product footprint
    - Disease footprint
    - Treatment footprint
    - End-user footprint
  • 11.6 COMPANY EVALUATION MATRIX: STARTUPS/SMES, 2023
    PROGRESSIVE COMPANIES
    RESPONSIVE COMPANIES
    DYNAMIC COMPANIES
    STARTING BLOCKS
    COMPETITIVE BENCHMARKING: STARTUPS/SMES, 2023
  • 11.7 COMPANY VALUATION & FINANCIAL METRICS
    FINANCIAL METRICS
    COMPANY VALUATION
  • 11.8 BRAND/PRODUCT COMPARISON
  • 11.9 R&D EXPENDITURE
  • 11.10 COMPETITIVE SCENARIO
    PRODUCT LAUNCHES & APPROVALS
    DEALS
    EXPANSIONS
COMPANY PROFILES
228
  • 12.1 KEY PLAYERS
    DENTSPLY SIRONA
    - Business overview
    - Products offered
    - Recent developments
    - MnM view
    ENVISTA HOLDINGS CORPORATION
    - Business overview
    - Products offered
    - Recent developments
    - MnM view
    INSTITUT STRAUMANN AG
    - Business overview
    - Products offered
    - Recent developments
    - MnM view
    HENRY SCHEIN, INC.
    - Business overview
    - Products offered
    - Recent developments
    - MnM view
    BIOLASE, INC.
    - Business overview
    - Products offered
    - Recent developments
    GEISTLICH PHARMA AG
    - Business overview
    - Products offered
    J. MORITA CORP.
    - Business overview
    - Products offered
    - Recent developments
    NAKANISHI INC.
    - Business overview
    - Products offered
    A-DEC INC.
    - Business overview
    - Products offered
    RTI SURGICAL
    - Business overview
    - Products offered
    - Recent developments
    YOSHIDA DENTAL MFG.CO. LTD.
    - Business overview
    - Products offered
    KEYSTONE DENTAL INC.
    - Business overview
    - Products offered
    - Recent developments
    ULTRADENT PRODUCTS, INC.
    - Business overview
    - Products offered
    BEGO GMBH & CO. KG
    - Business overview
    - Products offered
    - Recent developments
    DENTALEZ INC.
    - Business overview
    - Products offered
    - Recent developments
    PARKELL, INC.
    - Business overview
    - Products offered
    - Recent developments
  • 12.2 OTHER PLAYERS
    MILLENNIUM DENTAL TECHNOLOGIES INC.
    BRASSELER USA
    AMD LASERS
    NOVA INSTRUMENTS
    BOTISS BIOMATERIALS GMBH
    CONVERGENT DENTAL
    NOVABONE
    REGENITY
    HANNOX INTERNATIONAL CORP.
APPENDIX
271
  • 13.1 DISCUSSION GUIDE
  • 13.2 KNOWLEDGESTORE: MARKETSANDMARKETS’ SUBSCRIPTION PORTAL
  • 13.3 CUSTOMIZATION OPTIONS
  • 13.4 RELATED REPORTS
  • 13.5 AUTHOR DETAILS
LIST OF TABLES
 
  • TABLE 1 CURRENCY CONVERSION RATE, 2019–2023 (UNIT OF USD)
  • TABLE 2 PERIODONTAL DISEASE TREATMENT MARKET: RISK ASSESSMENT ANALYSIS
  • TABLE 3 INCREASE IN GERIATRIC POPULATION, BY COUNTRY (2022)
  • TABLE 4 AVERAGE PROCEDURAL COSTS IN TOP TEN DENTALTOURISM DESTINATIONS (USD)
  • TABLE 5 LIST OF RECENT DEALS BY PRIVATE EQUITIES IN US, 2020–2023
  • TABLE 6 PER CAPITA NATIONAL INCOME, 2000–2020 (USD)
  • TABLE 7 KEY ACQUISITIONS (2019−2024)
  • TABLE 8 NORTH AMERICA: REGULATORY BODIES, GOVERNMENT AGENCIES, AND OTHER ORGANIZATIONS
  • TABLE 9 EUROPE: REGULATORY BODIES, GOVERNMENT AGENCIES, AND OTHER ORGANIZATIONS
  • TABLE 10 ASIA PACIFIC: REGULATORY BODIES, GOVERNMENT AGENCIES, AND OTHER ORGANIZATIONS
  • TABLE 11 LATIN AMERICA: REGULATORY BODIES, GOVERNMENT AGENCIES, AND OTHER ORGANIZATIONS
  • TABLE 12 MIDDLE EAST & AFRICA: REGULATORY BODIES, GOVERNMENT AGENCIES, AND OTHER ORGANIZATIONS
  • TABLE 13 PERIODONTAL DISEASE TREATMENT: LIST OF MAJOR PATENTS
  • TABLE 14 US PERIODONTAL DISEASE TREATMENT AND SUPPLIES: EXPORTS, 2015–2022 (IN 000’)
  • TABLE 15 US INSTRUMENTS AND APPLIANCES USED IN MEDICAL, SURGICAL, DENTAL OR VETERINARY SCIENCES: EXPORTS, 2019–2022 (IN 000’)
  • TABLE 16 PERIODONTAL DISEASE TREATMENT MARKET: PORTER’S FIVE FORCES ANALYSIS
  • TABLE 17 KEY CONFERENCES & EVENTS, 2024
  • TABLE 18 AVERAGE COST OF PERIODONTAL DISEASE TREATMENT SYSTEMS, (2021−2023) (USD)
  • TABLE 19 AVERAGE COST RANGE OF PERIODONTAL DISEASE TREATMENT, BY REGION (2021−2023) (USD)
  • TABLE 20 INFLUENCE OF STAKEHOLDERS ON BUYING PROCESS FOR PERIODONTAL DISEASE TREATMENT
  • TABLE 21 PERIODONTAL DISEASE TREATMENT MARKET: UNMET NEEDS
  • TABLE 22 IMPACT OF AI/GEN AI ON PERIODONTAL DISEASE TREATMENT MARKET
  • TABLE 23 PERIODONTAL DISEASE TREATMENT MARKET: PREVALENCE OF GINGIVITIS, BY KEY COUNTRIES
  • TABLE 24 PERIODONTAL DISEASE TREATMENT MARKET: ANALYSIS OF TOTAL SURGERIES, BY KEY COUNTRY
  • TABLE 25 PERIODONTAL DISEASE TREATMENT MARKET, BY PRODUCT, 2022–2030 (USD MILLION)
  • TABLE 26 PERIODONTAL DISEASE TREATMENT MARKET FOR EQUIPMENT, BY COUNTRY, 2022–2030 (USD MILLION)
  • TABLE 27 PERIODONTAL DISEASE TREATMENT MARKET FOR CONSUMABLES, BY COUNTRY, 2022–2030 (USD MILLION)
  • TABLE 28 PERIODONTAL DISEASE TREATMENT MARKET FOR MEDICATION, BY COUNTRY, 2022–2030 (USD MILLION)
  • TABLE 29 PERIODONTAL DISEASE TREATMENT MARKET, BY DISEASE, 2022–2030 (USD MILLION)
  • TABLE 30 GINGIVITIS MARKET, BY TYPE, 2022–2030 (USD MILLION)
  • TABLE 31 GINGIVITIS MARKET, BY COUNTRY, 2022–2030 (USD MILLION)
  • TABLE 32 ACUTE GINGIVITIS MARKET, BY COUNTRY, 2022–2030 (USD MILLION)
  • TABLE 33 RECURRENT GINGIVITIS MARKET, BY COUNTRY, 2022–2030 (USD MILLION)
  • TABLE 34 CHRONIC GINGIVITIS MARKET, BY COUNTRY, 2022–2030 (USD MILLION)
  • TABLE 35 CHRONIC PERIODONTITIS MARKET, BY COUNTRY, 2022–2030 (USD MILLION)
  • TABLE 36 AGGRESSIVE PERIODONTITIS MARKET, BY COUNTRY, 2022–2030 (USD MILLION)
  • TABLE 37 OTHER DISEASES MARKET, BY COUNTRY, 2022–2030 (USD MILLION)
  • TABLE 38 PERIODONTAL DISEASE TREATMENT MARKET, BY TREATMENT, 2022–2030 (USD MILLION)
  • TABLE 39 NON-SURGICAL TREATMENT MARKET, BY TYPE, 2022–2030 (USD MILLION)
  • TABLE 40 NON-SURGICAL TREATMENT MARKET, BY COUNTRY, 2022–2030 (USD MILLION)
  • TABLE 41 NON-SURGICAL TREATMENT MARKET FOR SCALING, BY COUNTRY, 2022–2030 (USD MILLION)
  • TABLE 42 NON-SURGICAL TREATMENT MARKET FOR ROOT PLANING, BY COUNTRY, 2022–2030 (USD MILLION)
  • TABLE 43 NON-SURGICAL TREATMENT MARKET FOR MEDICATION THERAPY, BY TYPE, 2022–2030 (USD MILLION)
  • TABLE 44 NON-SURGICAL TREATMENT MARKET FOR MEDICATION THERAPY, BY COUNTRY, 2022–2030 (USD MILLION)
  • TABLE 45 TOPICAL THERAPY MARKET, BY COUNTRY, 2022–2030 (USD MILLION)
  • TABLE 46 SYSTEMIC THERAPY MARKET, BY COUNTRY, 2022–2030 (USD MILLION)
  • TABLE 47 FLAP SURGERY/POCKET REDUCTION THERAPY MARKET, BY COUNTRY, 2022–2030 (USD MILLION)
  • TABLE 48 SOFT TISSUE GRAFT MARKET, BY COUNTRY, 2022–2030 (USD MILLION)
  • TABLE 49 BONE GRAFTING MARKET, BY COUNTRY, 2022–2030 (USD MILLION)
  • TABLE 50 GUIDED TISSUE REGENERATION MARKET, BY COUNTRY, 2022–2030 (USD MILLION)
  • TABLE 51 OTHER TREATMENTS MARKET, BY COUNTRY, 2022–2030 (USD MILLION)
  • TABLE 52 PERIODONTAL DISEASE TREATMENT MARKET, BY END USER, 2022–2030 (USD MILLION)
  • TABLE 53 LEADING DESTINATIONS FOR COST-EFFICIENT DENTAL TREATMENT
  • TABLE 54 PERIODONTAL DISEASE TREATMENT MARKET FOR HOSPITALS, BY COUNTRY, 2022–2030 (USD MILLION)
  • TABLE 55 PERIODONTAL DISEASE TREATMENT MARKET FOR PRIVATE & DSO CLINICS, BY COUNTRY, 2022–2030 (USD MILLION)
  • TABLE 56 PERIODONTAL DISEASE TREATMENT MARKET FOR ACADEMIC & RESEARCH INSTITUTES, BY COUNTRY, 2022–2030 (USD MILLION)
  • TABLE 57 PERIODONTAL DISEASE TREATMENT MARKET, BY REGION, 2022–2030 (USD MILLION)
  • TABLE 58 NORTH AMERICA: PERIODONTAL DISEASE TREATMENT MARKET, BY COUNTRY, 2022–2030 (USD MILLION)
  • TABLE 59 NORTH AMERICA: PERIODONTAL DISEASE TREATMENT MARKET, BY PRODUCT, 2022–2030 (USD MILLION)
  • TABLE 60 NORTH AMERICA: PERIODONTAL DISEASE TREATMENT MARKET, BY DISEASE, 2022–2030 (USD MILLION)
  • TABLE 61 NORTH AMERICA: PERIODONTAL DISEASE TREATMENT MARKET FOR GINGIVITIS, BY TYPE, 2022–2030 (USD MILLION)
  • TABLE 62 NORTH AMERICA: PERIODONTAL DISEASE TREATMENT MARKET, BY TREATMENT, 2022–2030 (USD MILLION)
  • TABLE 63 NORTH AMERICA: NON-SURGICAL TREATMENT MARKET, BY TYPE, 2022–2030 (USD MILLION)
  • TABLE 64 NORTH AMERICA: PERIODONTAL DISEASE TREATMENT MARKET FOR MEDICATION THERAPY, BY TYPE, 2022–2030 (USD MILLION)
  • TABLE 65 NORTH AMERICA: PERIODONTAL DISEASE TREATMENT MARKET, BY END USER, 2022–2030 (USD MILLION)
  • TABLE 66 US: MACROECONOMIC INDICATORS
  • TABLE 67 US: PERIODONTAL DISEASE TREATMENT MARKET, BY PRODUCT, 2022–2030 (USD MILLION)
  • TABLE 68 US: PERIODONTAL DISEASE TREATMENT MARKET, BY DISEASE,2022–2030 (USD MILLION)
  • TABLE 69 US: PERIODONTAL DISEASE TREATMENT MARKET FOR GINGIVITIS, BY TYPE, 2022–2030 (USD MILLION)
  • TABLE 70 US: PERIODONTAL DISEASE TREATMENT MARKET, BY TREATMENT TYPE, 2022–2030 (USD MILLION)
  • TABLE 71 US: NON-SURGICAL TREATMENT MARKET, BY TYPE, 2022–2030 (USD MILLION)
  • TABLE 72 US: PERIODONTAL DISEASE TREATMENT MARKET FOR MEDICATION THERAPY, BY TYPE, 2022–2030 (USD MILLION)
  • TABLE 73 US: PERIODONTAL DISEASE TREATMENT MARKET, BY END USER, 2022–2030 (USD MILLION)
  • TABLE 74 CANADA: MACROECONOMIC INDICATORS
  • TABLE 75 CANADA: PERIODONTAL DISEASE TREATMENT MARKET, BY PRODUCT,2022–2030 (USD MILLION)
  • TABLE 76 CANADA: PERIODONTAL DISEASE TREATMENT MARKET, BY DISEASE, 2022–2030 (USD MILLION)
  • TABLE 77 CANADA: PERIODONTAL DISEASE TREATMENT MARKET FOR GINGIVITIS, BY TYPE, 2022–2030 (USD MILLION)
  • TABLE 78 CANADA: PERIODONTAL DISEASE TREATMENT MARKET, BY TREATMENT, 2022–2030 (USD MILLION)
  • TABLE 79 CANADA: NON-SURGICAL TREATMENT MARKET, BY TYPE, 2022–2030 (USD MILLION)
  • TABLE 80 CANADA: PERIODONTAL DISEASE TREATMENT MARKET FOR MEDICATION THERAPY, BY TYPE, 2022–2030 (USD MILLION)
  • TABLE 81 CANADA: PERIODONTAL DISEASE TREATMENT MARKET, BY END USER, 2022–2030 (USD MILLION)
  • TABLE 82 EUROPE: PERIODONTAL DISEASE TREATMENT MARKET, BY COUNTRY, 2022–2030 (USD MILLION)
  • TABLE 83 EUROPE: PERIODONTAL DISEASE TREATMENT MARKET, BY PRODUCT, 2022–2030 (USD MILLION)
  • TABLE 84 EUROPE: PERIODONTAL DISEASE TREATMENT MARKET, BY DISEASE, 2022–2030 (USD MILLION)
  • TABLE 85 EUROPE: PERIODONTAL DISEASE TREATMENT MARKET FOR GINGIVITIS, BY TYPE, 2022–2030 (USD MILLION)
  • TABLE 86 EUROPE: PERIODONTAL DISEASE TREATMENT MARKET, BY TREATMENT, 2022–2030 (USD MILLION)
  • TABLE 87 EUROPE: NON-SURGICAL TREATMENT MARKET, BY TYPE, 2022–2030 (USD MILLION)
  • TABLE 88 EUROPE: PERIODONTAL DISEASE TREATMENT MARKET FOR MEDICATION THERAPY, BY TYPE, 2022–2030 (USD MILLION)
  • TABLE 89 EUROPE: PERIODONTAL DISEASE TREATMENT MARKET, BY END USER, 2022–2030 (USD MILLION)
  • TABLE 90 GERMANY: MACROECONOMIC INDICATORS
  • TABLE 91 GERMANY: PERIODONTAL DISEASE TREATMENT MARKET, BY PRODUCT, 2022–2030 (USD MILLION)
  • TABLE 92 GERMANY: PERIODONTAL DISEASE TREATMENT MARKET, BY DISEASE, 2022–2030 (USD MILLION)
  • TABLE 93 GERMANY: PERIODONTAL DISEASE TREATMENT MARKET FOR GINGIVITIS, BY TYPE, 2022–2030 (USD MILLION)
  • TABLE 94 GERMANY: PERIODONTAL DISEASE TREATMENT MARKET, BY TREATMENT,2022–2030 (USD MILLION)
  • TABLE 95 GERMANY: NON-SURGICAL TREATMENT MARKET, BY TYPE, 2022–2030 (USD MILLION)
  • TABLE 96 GERMANY: PERIODONTAL DISEASE TREATMENT MARKET FOR MEDICATION THERAPY, BY TYPE, 2022–2030 (USD MILLION)
  • TABLE 97 GERMANY: PERIODONTAL DISEASE TREATMENT MARKET, BY END USER, 2022–2030 (USD MILLION)
  • TABLE 98 FRANCE: MACROECONOMIC INDICATORS
  • TABLE 99 FRANCE: PERIODONTAL DISEASE TREATMENT MARKET, BY PRODUCT, 2022–2030 (USD MILLION)
  • TABLE 100 FRANCE: PERIODONTAL DISEASE TREATMENT MARKET, BY DISEASE, 2022–2030 (USD MILLION)
  • TABLE 101 FRANCE: PERIODONTAL DISEASE TREATMENT MARKET FOR GINGIVITIS, BY TYPE, 2022–2030 (USD MILLION)
  • TABLE 102 FRANCE: PERIODONTAL DISEASE TREATMENT MARKET, BY TREATMENT TYPE, 2022–2030 (USD MILLION)
  • TABLE 103 FRANCE: NON-SURGICAL TREATMENT MARKET, BY TYPE, 2022–2030 (USD MILLION)
  • TABLE 104 FRANCE: PERIODONTAL DISEASE TREATMENT MARKET FOR MEDICATION THERAPY, BY TYPE, 2022–2030 (USD MILLION)
  • TABLE 105 FRANCE: PERIODONTAL DISEASE TREATMENT MARKET, BY END USER, 2022–2030 (USD MILLION)
  • TABLE 106 UK: MACROECONOMIC INDICATORS
  • TABLE 107 UK: PERIODONTAL DISEASE TREATMENT MARKET, BY PRODUCT, 2022–2030 (USD MILLION)
  • TABLE 108 UK: PERIODONTAL DISEASE TREATMENT MARKET, BY DISEASE, 2022–2030 (USD MILLION)
  • TABLE 109 UK: PERIODONTAL DISEASE TREATMENT MARKET FOR GINGIVITIS, BY TYPE, 2022–2030 (USD MILLION)
  • TABLE 110 UK: PERIODONTAL DISEASE TREATMENT MARKET, BY TREATMENT, 2022–2030 (USD MILLION)
  • TABLE 111 UK: NON-SURGICAL TREATMENT MARKET, BY TYPE, 2022–2030 (USD MILLION)
  • TABLE 112 UK: PERIODONTAL DISEASE TREATMENT MARKET FOR MEDICATION THERAPY, BY TYPE, 2022–2030 (USD MILLION)
  • TABLE 113 UK: PERIODONTAL DISEASE TREATMENT MARKET, BY END USER, 2022–2030 (USD MILLION)
  • TABLE 114 ITALY: MACROECONOMIC INDICATORS
  • TABLE 115 ITALY: PERIODONTAL DISEASE TREATMENT MARKET, BY PRODUCT, 2022–2030 (USD MILLION)
  • TABLE 116 ITALY: PERIODONTAL DISEASE TREATMENT MARKET, BY DISEASE, 2022–2030 (USD MILLION)
  • TABLE 117 ITALY: PERIODONTAL DISEASE TREATMENT MARKET FOR GINGIVITIS, BY TYPE, 2022–2030 (USD MILLION)
  • TABLE 118 ITALY: PERIODONTAL DISEASE TREATMENT MARKET, BY TREATMENT, 2022–2030 (USD MILLION)
  • TABLE 119 ITALY: NON-SURGICAL TREATMENT MARKET, BY TYPE, 2022–2030 (USD MILLION)
  • TABLE 120 ITALY: PERIODONTAL DISEASE TREATMENT MARKET FOR MEDICATION THERAPY, BY TYPE, 2022–2030 (USD MILLION)
  • TABLE 121 ITALY: PERIODONTAL DISEASE TREATMENT MARKET, BY END USER, 2022–2030 (USD MILLION)
  • TABLE 122 SPAIN: MACROECONOMIC INDICATORS
  • TABLE 123 SPAIN: PERIODONTAL DISEASE TREATMENT MARKET, BY PRODUCT, 2022–2030 (USD MILLION)
  • TABLE 124 SPAIN: PERIODONTAL DISEASE TREATMENT MARKET, BY DISEASE, 2022–2030 (USD MILLION)
  • TABLE 125 SPAIN: PERIODONTAL DISEASE TREATMENT MARKET FOR GINGIVITIS, BY TYPE, 2022–2030 (USD MILLION)
  • TABLE 126 SPAIN: PERIODONTAL DISEASE TREATMENT MARKET, BY TREATMENT, 2022–2030 (USD MILLION)
  • TABLE 127 SPAIN: NON-SURGICAL TREATMENT MARKET, BY TYPE, 2022–2030 (USD MILLION)
  • TABLE 128 SPAIN: PERIODONTAL DISEASE TREATMENT MARKET FOR MEDICATION THERAPY, BY TYPE, 2022–2030 (USD MILLION)
  • TABLE 129 SPAIN: PERIODONTAL DISEASE TREATMENT MARKET, BY END USER, 2022–2030 (USD MILLION)
  • TABLE 130 REST OF EUROPE: PERIODONTAL DISEASE TREATMENT MARKET, BY PRODUCT, 2022–2030 (USD MILLION)
  • TABLE 131 REST OF EUROPE: PERIODONTAL DISEASE TREATMENT MARKET, BY DISEASE, 2022–2030 (USD MILLION)
  • TABLE 132 REST OF EUROPE: PERIODONTAL DISEASE TREATMENT MARKET FOR GINGIVITIS, BY TYPE, 2022–2030 (USD MILLION)
  • TABLE 133 REST OF EUROPE: PERIODONTAL DISEASE TREATMENT MARKET, BY TREATMENT, 2022–2030 (USD MILLION)
  • TABLE 134 REST OF EUROPE: NON-SURGICAL TREATMENT MARKET, BY TYPE, 2022–2030 (USD MILLION)
  • TABLE 135 REST OF EUROPE: PERIODONTAL DISEASE TREATMENT MARKET FOR MEDICATION THERAPY, BY TYPE, 2022–2030 (USD MILLION)
  • TABLE 136 REST OF EUROPE: PERIODONTAL DISEASE TREATMENT MARKET, BY END USER, 2022–2030 (USD MILLION)
  • TABLE 137 ASIA PACIFIC: PERIODONTAL DISEASE TREATMENT MARKET, BY COUNTRY, 2022–2030 (USD MILLION)
  • TABLE 138 ASIA PACIFIC: PERIODONTAL DISEASE TREATMENT MARKET, BY PRODUCT, 2022–2030 (USD MILLION)
  • TABLE 139 ASIA PACIFIC: PERIODONTAL DISEASE TREATMENT MARKET, BY DISEASE, 2022–2030 (USD MILLION)
  • TABLE 140 ASIA PACIFIC: PERIODONTAL DISEASE TREATMENT MARKET FOR GINGIVITIS, BY TYPE, 2022–2030 (USD MILLION)
  • TABLE 141 ASIA PACIFIC: PERIODONTAL DISEASE TREATMENT MARKET, BY TREATMENT, 2022–2030 (USD MILLION)
  • TABLE 142 ASIA PACIFIC: NON-SURGICAL TREATMENT MARKET, BY TYPE, 2022–2030 (USD MILLION)
  • TABLE 143 ASIA PACIFIC: PERIODONTAL DISEASE TREATMENT MARKET FOR MEDICATION THERAPY, BY TYPE, 2022–2030 (USD MILLION)
  • TABLE 144 ASIA PACIFIC: PERIODONTAL DISEASE TREATMENT MARKET, BY END USER, 2022–2030 (USD MILLION)
  • TABLE 145 CHINA: MACROECONOMIC INDICATORS
  • TABLE 146 CHINA: PERIODONTAL DISEASE TREATMENT MARKET, BY PRODUCT, 2022–2030 (USD MILLION)
  • TABLE 147 CHINA: PERIODONTAL DISEASE TREATMENT MARKET, BY DISEASE, 2022–2030 (USD MILLION)
  • TABLE 148 CHINA: PERIODONTAL DISEASE TREATMENT MARKET FOR GINGIVITIS, BY TYPE, 2022–2030 (USD MILLION)
  • TABLE 149 CHINA: PERIODONTAL DISEASE TREATMENT MARKET, BY TREATMENT, 2022–2030 (USD MILLION)
  • TABLE 150 CHINA: NON-SURGICAL TREATMENT MARKET, BY TYPE, 2022–2030 (USD MILLION)
  • TABLE 151 CHINA: PERIODONTAL DISEASE TREATMENT MARKET FOR MEDICATION THERAPY, BY TYPE, 2022–2030 (USD MILLION)
  • TABLE 152 CHINA: PERIODONTAL DISEASE TREATMENT MARKET, BY END USER, 2022–2030 (USD MILLION)
  • TABLE 153 JAPAN: MACROECONOMIC INDICATORS
  • TABLE 154 JAPAN: PERIODONTAL DISEASE TREATMENT MARKET, BY PRODUCT, 2022–2030 (USD MILLION)
  • TABLE 155 JAPAN: PERIODONTAL DISEASE TREATMENT MARKET, BY DISEASE,2022–2030 (USD MILLION)
  • TABLE 156 JAPAN: PERIODONTAL DISEASE TREATMENT MARKET FOR GINGIVITIS, BY TYPE, 2022–2030 (USD MILLION)
  • TABLE 157 JAPAN: PERIODONTAL DISEASE TREATMENT MARKET, BY TREATMENT, 2022–2030 (USD MILLION)
  • TABLE 158 JAPAN: NON-SURGICAL TREATMENT MARKET, BY TYPE, 2022–2030 (USD MILLION)
  • TABLE 159 JAPAN: PERIODONTAL DISEASE TREATMENT MARKET FOR MEDICATION THERAPY, BY TYPE, 2022–2030 (USD MILLION)
  • TABLE 160 JAPAN: PERIODONTAL DISEASE TREATMENT MARKET, BY END USER, 2022–2030 (USD MILLION)
  • TABLE 161 INDIA: MACROECONOMIC INDICATORS
  • TABLE 162 INDIA: PERIODONTAL DISEASE TREATMENT MARKET, BY PRODUCT, 2022–2030 (USD MILLION)
  • TABLE 163 INDIA: PERIODONTAL DISEASE TREATMENT MARKET, BY DISEASE, 2022–2030 (USD MILLION)
  • TABLE 164 INDIA: PERIODONTAL DISEASE TREATMENT MARKET FOR GINGIVITIS, BY TYPE, 2022–2030 (USD MILLION)
  • TABLE 165 INDIA: PERIODONTAL DISEASE TREATMENT MARKET, BY TREATMENT, 2022–2030 (USD MILLION)
  • TABLE 166 INDIA: NON-SURGICAL TREATMENT MARKET, BY TYPE, 2022–2030 (USD MILLION)
  • TABLE 167 INDIA: PERIODONTAL DISEASE TREATMENT MARKET FOR MEDICATION THERAPY, BY TYPE, 2022–2030 (USD MILLION)
  • TABLE 168 INDIA: PERIODONTAL DISEASE TREATMENT MARKET, BY END USER, 2022–2030 (USD MILLION)
  • TABLE 169 AUSTRALIA: MACROECONOMIC INDICATORS
  • TABLE 170 AUSTRALIA: PERIODONTAL DISEASE TREATMENT MARKET, BY PRODUCT, 2022–2030 (USD MILLION)
  • TABLE 171 AUSTRALIA: PERIODONTAL DISEASE TREATMENT MARKET, BY DISEASE, 2022–2030 (USD MILLION)
  • TABLE 172 AUSTRALIA: PERIODONTAL DISEASE TREATMENT MARKET FOR GINGIVITIS, BY TYPE, 2022–2030 (USD MILLION)
  • TABLE 173 AUSTRALIA: PERIODONTAL DISEASE TREATMENT MARKET, BY TREATMENT, 2022–2030 (USD MILLION)
  • TABLE 174 AUSTRALIA: NON-SURGICAL TREATMENT MARKET, BY TYPE, 2022–2030 (USD MILLION)
  • TABLE 175 AUSTRALIA: PERIODONTAL DISEASE TREATMENT MARKET FOR MEDICATION THERAPY, BY TYPE, 2022–2030 (USD MILLION)
  • TABLE 176 AUSTRALIA: PERIODONTAL DISEASE TREATMENT MARKET, BY END USER, 2022–2030 (USD MILLION)
  • TABLE 177 SOUTH KOREA: MACROECONOMIC INDICATORS
  • TABLE 178 SOUTH KOREA: PERIODONTAL DISEASE TREATMENT MARKET, BY PRODUCT, 2022–2030 (USD MILLION)
  • TABLE 179 SOUTH KOREA: PERIODONTAL DISEASE TREATMENT MARKET, BY DISEASE, 2022–2030 (USD MILLION)
  • TABLE 180 SOUTH KOREA: PERIODONTAL DISEASE TREATMENT MARKET FOR GINGIVITIS, BY TYPE, 2022–2030 (USD MILLION)
  • TABLE 181 SOUTH KOREA: PERIODONTAL DISEASE TREATMENT MARKET, BY TREATMENT, 2022–2030 (USD MILLION)
  • TABLE 182 SOUTH KOREA: NON-SURGICAL TREATMENT MARKET, BY TYPE, 2022–2030 (USD MILLION)
  • TABLE 183 SOUTH KOREA: PERIODONTAL DISEASE TREATMENT MARKET FOR MEDICATION THERAPY, BY TYPE, 2022–2030 (USD MILLION)
  • TABLE 184 SOUTH KOREA: PERIODONTAL DISEASE TREATMENT MARKET, BY END USER, 2022–2030 (USD MILLION)
  • TABLE 185 REST OF ASIA PACIFIC: PERIODONTAL DISEASE TREATMENT MARKET, BY PRODUCT, 2022–2030 (USD MILLION)
  • TABLE 186 REST OF ASIA PACIFIC: PERIODONTAL DISEASE TREATMENT MARKET, BY DISEASE, 2022–2030 (USD MILLION)
  • TABLE 187 REST OF ASIA PACIFIC: PERIODONTAL DISEASE TREATMENT MARKET FOR GINGIVITIS, BY TYPE, 2022–2030 (USD MILLION)
  • TABLE 188 REST OF ASIA PACIFIC: PERIODONTAL DISEASE TREATMENT MARKET, BY TREATMENT, 2022–2030 (USD MILLION)
  • TABLE 189 REST OF ASIA PACIFIC: NON-SURGICAL TREATMENT MARKET, BY TYPE, 2022–2030 (USD MILLION)
  • TABLE 190 REST OF ASIA PACIFIC: PERIODONTAL DISEASE TREATMENT MARKET FOR MEDICATION THERAPY, BY TYPE, 2022–2030 (USD MILLION)
  • TABLE 191 REST OF ASIA PACIFIC: PERIODONTAL DISEASE TREATMENT MARKET, BY END USER, 2022–2030 (USD MILLION)
  • TABLE 192 LATIN AMERICA: PERIODONTAL DISEASE TREATMENT MARKET, BY COUNTRY, 2022–2030 (USD MILLION)
  • TABLE 193 LATIN AMERICA: PERIODONTAL DISEASE TREATMENT MARKET, BY PRODUCT, 2022–2030 (USD MILLION)
  • TABLE 194 LATIN AMERICA: PERIODONTAL DISEASE TREATMENT MARKET, BY DISEASE, 2022–2030 (USD MILLION)
  • TABLE 195 LATIN AMERICA: PERIODONTAL DISEASE TREATMENT MARKET FOR GINGIVITIS, BY TYPE, 2022–2030 (USD MILLION)
  • TABLE 196 LATIN AMERICA: PERIODONTAL DISEASE TREATMENT MARKET, BY TREATMENT, 2022–2030 (USD MILLION)
  • TABLE 197 LATIN AMERICA: NON-SURGICAL TREATMENT MARKET, BY TYPE, 2022–2030 (USD MILLION)
  • TABLE 198 LATIN AMERICA: PERIODONTAL DISEASE TREATMENT MARKET FOR MEDICATION THERAPY, BY TYPE, 2022–2030 (USD MILLION)
  • TABLE 199 LATIN AMERICA: PERIODONTAL DISEASE TREATMENT MARKET, BY END USER, 2022–2030 (USD MILLION)
  • TABLE 200 MEXICO: MACROECONOMIC INDICATORS
  • TABLE 201 MEXICO: PERIODONTAL DISEASE TREATMENT MARKET, BY PRODUCT, 2022–2030 (USD MILLION)
  • TABLE 202 MEXICO: PERIODONTAL DISEASE TREATMENT MARKET, BY DISEASE, 2022–2030 (USD MILLION)
  • TABLE 203 MEXICO: PERIODONTAL DISEASE TREATMENT MARKET FOR GINGIVITIS, BY TYPE, 2022–2030 (USD MILLION)
  • TABLE 204 MEXICO: PERIODONTAL DISEASE TREATMENT MARKET, BY TREATMENT, 2022–2030 (USD MILLION)
  • TABLE 205 MEXICO: NON-SURGICAL TREATMENT MARKET, BY TYPE, 2022–2030 (USD MILLION)
  • TABLE 206 MEXICO: PERIODONTAL DISEASE TREATMENT MARKET FOR MEDICATION THERAPY, BY TYPE, 2022–2030 (USD MILLION)
  • TABLE 207 MEXICO: PERIODONTAL DISEASE TREATMENT MARKET, BY END USER, 2022–2030 (USD MILLION)
  • TABLE 208 BRAZIL: MACROECONOMIC INDICATORS
  • TABLE 209 BRAZIL: PERIODONTAL DISEASE TREATMENT MARKET, BY PRODUCT, 2022–2030 (USD MILLION)
  • TABLE 210 BRAZIL: PERIODONTAL DISEASE TREATMENT MARKET, BY DISEASE, 2022–2030 (USD MILLION)
  • TABLE 211 BRAZIL: PERIODONTAL DISEASE TREATMENT MARKET FOR GINGIVITIS, BY TYPE, 2022–2030 (USD MILLION)
  • TABLE 212 BRAZIL: PERIODONTAL DISEASE TREATMENT MARKET, BY TREATMENT, 2022–2030 (USD MILLION)
  • TABLE 213 BRAZIL: NON-SURGICAL TREATMENT MARKET, BY TYPE, 2022–2030 (USD MILLION)
  • TABLE 214 BRAZIL: PERIODONTAL DISEASE TREATMENT MARKET FOR MEDICATION THERAPY, BY TYPE, 2022–2030 (USD MILLION)
  • TABLE 215 BRAZIL: PERIODONTAL DISEASE TREATMENT MARKET, BY END USER, 2022–2030 (USD MILLION)
  • TABLE 216 ARGENTINA: MACROECONOMIC INDICATORS
  • TABLE 217 ARGENTINA: PERIODONTAL DISEASE TREATMENT MARKET, BY PRODUCT, 2022–2030 (USD MILLION)
  • TABLE 218 ARGENTINA: PERIODONTAL DISEASE TREATMENT MARKET, BY DISEASE, 2022–2030 (USD MILLION)
  • TABLE 219 ARGENTINA: PERIODONTAL DISEASE TREATMENT MARKET FOR GINGIVITIS, BY TYPE, 2022–2030 (USD MILLION)
  • TABLE 220 ARGENTINA: PERIODONTAL DISEASE TREATMENT MARKET, BY TREATMENT, 2022–2030 (USD MILLION)
  • TABLE 221 ARGENTINA: NON-SURGICAL TREATMENT MARKET, BY TYPE, 2022–2030 (USD MILLION)
  • TABLE 222 ARGENTINA: PERIODONTAL DISEASE TREATMENT MARKET FOR MEDICATION THERAPY, BY TYPE, 2022–2030 (USD MILLION)
  • TABLE 223 ARGENTINA: PERIODONTAL DISEASE TREATMENT MARKET, BY END USER, 2022–2030 (USD MILLION)
  • TABLE 224 REST OF LATIN AMERICA: PERIODONTAL DISEASE TREATMENT MARKET, BY PRODUCT, 2022–2030 (USD MILLION)
  • TABLE 225 REST OF LATIN AMERICA: PERIODONTAL DISEASE TREATMENT MARKET, BY DISEASE, 2022–2030 (USD MILLION)
  • TABLE 226 REST OF LATIN AMERICA: PERIODONTAL DISEASE TREATMENT MARKET FOR GINGIVITIS, BY TYPE, 2022–2030 (USD MILLION)
  • TABLE 227 REST OF LATIN AMERICA: PERIODONTAL DISEASE TREATMENT MARKET, BY TREATMENT, 2022–2030 (USD MILLION)
  • TABLE 228 REST OF LATIN AMERICA: NON-SURGICAL TREATMENT MARKET, BY TYPE, 2022–2030 (USD MILLION)
  • TABLE 229 REST OF LATIN AMERICA: PERIODONTAL DISEASE TREATMENT MARKET FOR MEDICATION THERAPY, BY TYPE, 2022–2030 (USD MILLION)
  • TABLE 230 REST OF LATIN AMERICA: PERIODONTAL DISEASE TREATMENT MARKET, BY END USER, 2022–2030 (USD MILLION)
  • TABLE 231 MIDDLE EAST & AFRICA: PERIODONTAL DISEASE TREATMENT MARKET, BY PRODUCT, 2022–2030 (USD MILLION)
  • TABLE 232 MIDDLE EAST & AFRICA: PERIODONTAL DISEASE TREATMENT MARKET, BY DISEASE, 2022–2030 (USD MILLION)
  • TABLE 233 MIDDLE EAST & AFRICA: PERIODONTAL DISEASE TREATMENT MARKET FOR GINGIVITIS, BY TYPE, 2022–2030 (USD MILLION)
  • TABLE 234 MIDDLE EAST & AFRICA: PERIODONTAL DISEASE TREATMENT MARKET, BY TREATMENT, 2022–2030 (USD MILLION)
  • TABLE 235 MIDDLE EAST & AFRICA: NON-SURGICAL TREATMENT MARKET, BY TYPE, 2022–2030 (USD MILLION)
  • TABLE 236 MIDDLE EAST & AFRICA: PERIODONTAL DISEASE TREATMENT MARKET FOR MEDICATION THERAPY, BY TYPE, 2022–2030 (USD MILLION)
  • TABLE 237 MIDDLE EAST & AFRICA: PERIODONTAL DISEASE TREATMENT MARKET, BY END USER, 2022–2030 (USD MILLION)
  • TABLE 238 GCC COUNTRIES: PERIODONTAL DISEASE TREATMENT MARKET, BY PRODUCT, 2022–2030 (USD MILLION)
  • TABLE 239 GCC COUNTRIES: PERIODONTAL DISEASE TREATMENT MARKET, BY DISEASE, 2022–2030 (USD MILLION)
  • TABLE 240 GCC COUNTRIES: PERIODONTAL DISEASE TREATMENT MARKET FOR GINGIVITIS, BY TYPE, 2022–2030 (USD MILLION)
  • TABLE 241 GCC COUNTRIES: PERIODONTAL DISEASE TREATMENT MARKET, BY TREATMENT, 2022–2030 (USD MILLION)
  • TABLE 242 GCC COUNTRIES: NON-SURGICAL TREATMENT MARKET, BY TYPE, 2022–2030 (USD MILLION)
  • TABLE 243 GCC COUNTRIES: PERIODONTAL DISEASE TREATMENT MARKET FOR MEDICATION THERAPY, BY TYPE, 2022–2030 (USD MILLION)
  • TABLE 244 GCC COUNTRIES: PERIODONTAL DISEASE TREATMENT MARKET, BY END USER, 2022–2030 (USD MILLION)
  • TABLE 245 PERIODONTAL DISEASE TREATMENT MARKET: DEGREE OF COMPETITION
  • TABLE 246 PERIODONTAL DISEASE TREATMENT MARKET: REGION FOOTPRINT
  • TABLE 247 PERIODONTAL DISEASE TREATMENT MARKET: PRODUCT FOOTPRINT
  • TABLE 248 PERIODONTAL DISEASE TREATMENT MARKET: DISEASE FOOTPRINT
  • TABLE 249 PERIODONTAL DISEASE TREATMENT MARKET: TREATMENT FOOTPRINT
  • TABLE 250 PERIODONTAL DISEASE TREATMENT MARKET: END-USER FOOTPRINT
  • TABLE 251 PERIODONTAL DISEASE TREATMENT MARKET: DETAILED LIST OF KEY STARTUP/SME PLAYERS
  • TABLE 252 PERIODONTAL DISEASE TREATMENT MARKET: COMPETITIVE BENCHMARKING OF KEY EMERGING PLAYERS/STARTUPS
  • TABLE 253 PERIODONTAL DISEASE TREATMENT MARKET: PRODUCT LAUNCHES & APPROVALS, JANUARY 2021–OCTOBER 2024
  • TABLE 254 PERIODONTAL DISEASE TREATMENT MARKET: DEALS, JANUARY 2021–OCTOBER 2024
  • TABLE 255 PERIODONTAL DISEASE TREATMENT MARKET: EXPANSIONS, JANUARY 2021–OCTOBER 2024
  • TABLE 256 DENTSPLY SIRONA: COMPANY OVERVIEW
  • TABLE 257 DENTSPLY SIRONA: PRODUCTS OFFERED
  • TABLE 258 DENTSPLY SIRONA: PRODUCT LAUNCHES, JANUARY 2021–OCTOBER 2024
  • TABLE 259 DENTSPLY SIRONA: DEALS, JANUARY 2021–OCTOBER 2024
  • TABLE 260 ENVISTA HOLDINGS CORPORATION: COMPANY OVERVIEW
  • TABLE 261 ENVISTA HOLDINGS CORPORATION: PRODUCTS OFFERED
  • TABLE 262 ENVISTA HOLDINGS CORPORATION: PRODUCT APPROVALS, JANUARY 2021–OCTOBER 2024
  • TABLE 263 ENVISTA HOLDINGS CORPORATION: DEALS
  • TABLE 264 INSTITUT STRAUMANN AG: COMPANY OVERVIEW
  • TABLE 265 INSTITUT STRAUMANN AG: PRODUCTS OFFERED
  • TABLE 266 INSTITUT STRAUMANN AG: PRODUCT LAUNCHES, JANUARY 2021–OCTOBER 2024
  • TABLE 267 INSTITUT STRAUMANN AG: DEALS, JANUARY 2021–OCTOBER 2024
  • TABLE 268 INSTITUT STRAUMANN AG: EXPANSIONS, JANUARY 2021–OCTOBER 2024
  • TABLE 269 HENRY SCHEIN, INC.: COMPANY OVERVIEW
  • TABLE 270 HENRY SCHEIN, INC.: PRODUCTS OFFERED
  • TABLE 271 HENRY SCHEIN, INC.: DEALS, JANUARY 2021–OCTOBER 2024
  • TABLE 272 BIOLASE INC.: COMPANY OVERVIEW
  • TABLE 273 BIOLASE INC.: PRODUCTS OFFERED
  • TABLE 274 BIOLASE INC.: PRODUCT LAUNCHES, JANUARY 2021–OCTOBER 2024
  • TABLE 275 GEISTLICH PHARMA AG: COMPANY OVERVIEW
  • TABLE 276 GEISTLICH PHARMA AG: PRODUCTS OFFERED
  • TABLE 277 J. MORITA CORP.: COMPANY OVERVIEW
  • TABLE 278 J. MORITA CORP.: PRODUCTS OFFERED
  • TABLE 279 J. MORITA CORP.: PRODUCT LAUNCHES, JANUARY 2021–OCTOBER 2024
  • TABLE 280 J. MORITA CORP.: DEALS, JANUARY 2021–OCTOBER 2024
  • TABLE 281 NAKANISHI INC.: COMPANY OVERVIEW
  • TABLE 282 NAKANISHI INC.: PRODUCTS OFFERED
  • TABLE 283 A-DEC INC.: COMPANY OVERVIEW
  • TABLE 284 A-DEC: PRODUCTS OFFERED
  • TABLE 285 RTI SURGICAL: COMPANY OVERVIEW
  • TABLE 286 RTI SURGICAL: PRODUCTS OFFERED
  • TABLE 287 RTI SURGICAL: DEALS, JANUARY 2021–OCTOBER 2024
  • TABLE 288 YOSHIDA DENTAL MFG.CO. LTD.: COMPANY OVERVIEW
  • TABLE 289 YOSHIDA DENTAL MFG.CO. LTD.: PRODUCTS OFFERED
  • TABLE 290 KEYSTONE DENTAL INC.: COMPANY OVERVIEW
  • TABLE 291 KEYSTONE DENTAL INC.: PRODUCTS OFFERED
  • TABLE 292 KEYSTONE DENTAL: DEALS, JANUARY 2021–OCTOBER 2024
  • TABLE 293 ULTRADENT PRODUCTS, INC.: COMPANY OVERVIEW
  • TABLE 294 ULTRADENT PRODUCTS, INC.: PRODUCTS OFFERED
  • TABLE 295 BEGO GMBH & CO. KG: COMPANY OVERVIEW
  • TABLE 296 BEGO GMBH & CO. KG: PRODUCTS OFFERED
  • TABLE 297 BEGO GMBH & CO. KG: DEALS, JANUARY 2021–OCTOBER 2024
  • TABLE 298 DENTALEZ INC.: COMPANY OVERVIEW
  • TABLE 299 DENTALEZ INC.: PRODUCTS OFFERED
  • TABLE 300 DENTALEZ INC.: PRODUCT LAUNCHES, JANUARY 2021–OCTOBER 2024
  • TABLE 301 PARKELL, INC.: COMPANY OVERVIEW
  • TABLE 302 PARKELL, INC.: PRODUCTS OFFERED
  • TABLE 303 PARKELL, INC.: PRODUCT LAUNCHES, JANUARY 2021–OCTOBER 2024
LIST OF FIGURES
 
  • FIGURE 1 RESEARCH DESIGN
  • FIGURE 2 PRIMARY SOURCES
  • FIGURE 3 BREAKDOWN OF PRIMARY INTERVIEWS: SUPPLY-SIDE AND DEMAND-SIDE PARTICIPANTS
  • FIGURE 4 BREAKDOWN OF PRIMARY INTERVIEWS: BY COMPANY TYPE, DESIGNATION, AND REGION
  • FIGURE 5 BREAKDOWN OF PRIMARY INTERVIEWS (DEMAND SIDE): BY END USER, DESIGNATION, AND REGION
  • FIGURE 6 SUPPLY-SIDE MARKET SIZE ESTIMATION: REVENUE SHARE ANALYSIS
  • FIGURE 7 INSTITUT STRAUMANN AG: REVENUE SHARE ANALYSIS ILLUSTRATION
  • FIGURE 8 SUPPLY-SIDE ANALYSIS: PERIODONTAL DISEASE TREATMENT MARKET (2023)
  • FIGURE 9 PERIODONTAL DISEASE TREATMENT MARKET: CAGR PROJECTIONS FROM ANALYSIS OF DRIVERS, RESTRAINTS, OPPORTUNITIES, AND CHALLENGES (2024–2030)
  • FIGURE 10 CAGR PROJECTIONS: SUPPLY-SIDE ANALYSIS
  • FIGURE 11 TOP-DOWN APPROACH
  • FIGURE 12 MARKET DATA TRIANGULATION METHODOLOGY
  • FIGURE 13 STUDY ASSUMPTIONS
  • FIGURE 14 PERIODONTAL DISEASE TREATMENT MARKET, BY PRODUCT,2024 VS. 2030 (USD MILLION)
  • FIGURE 15 PERIODONTAL DISEASE TREATMENT MARKET, BY DISEASE, 2024 VS. 2030 (USD MILLION)
  • FIGURE 16 PERIODONTAL DISEASE TREATMENT MARKET, BY TREATMENT, 2024 VS. 2030 (USD MILLION)
  • FIGURE 17 PERIODONTAL DISEASE TREATMENT MARKET, BY END USER, 2022 VS. 2029 (USD MILLION)
  • FIGURE 18 GEOGRAPHIC SNAPSHOT OF PERIODONTAL DISEASE TREATMENT MARKET
  • FIGURE 19 INCREASING PREVALENCE OF ORAL DISORDERS TO PROPEL MARKET
  • FIGURE 20 EQUIPMENT SEGMENT IN CHINA ACCOUNTED FOR LARGEST MARKET SHARE IN 2023
  • FIGURE 21 INDIA TO REGISTER HIGHEST GROWTH RATE DURING FORECAST PERIOD
  • FIGURE 22 NORTH AMERICA REGION TO DOMINATE MARKET DURING FORECAST PERIOD
  • FIGURE 23 PERIODONTAL DISEASE TREATMENT MARKET: DRIVERS, RESTRAINTS, OPPORTUNITIES, AND CHALLENGES
  • FIGURE 24 TOTAL DENTAL ENROLLMENT (2011–2020)
  • FIGURE 25 VALUE CHAIN ANALYSIS
  • FIGURE 26 PERIODONTAL DISEASE TREATMENT MARKET: ECOSYSTEM MAP
  • FIGURE 27 PATENT PUBLICATION TRENDS (2013–2024)
  • FIGURE 28 TOP APPLICANTS AND OWNERS (COMPANIES/INSTITUTES) FOR PERIODONTAL DISEASE TREATMENT PATENTS (2013–2024)
  • FIGURE 29 TOP 10 APPLICANT COUNTRIES/REGIONS FOR PERIODONTAL DISEASE TREATMENT PATENTS (2013–2024)
  • FIGURE 30 TRENDS/DISRUPTIONS IMPACTING CUSTOMERS’ BUSINESSES
  • FIGURE 31 ADJACENT MARKETS FOR PERIODONTAL DISEASE TREATMENT
  • FIGURE 32 PORTER’S FIVE FORCES ANALYSIS
  • FIGURE 33 AVERAGE SELLING PRICE OF PERIODONTAL DISEASE TREATMENT, BY PRODUCT TYPE
  • FIGURE 34 INFLUENCE OF STAKEHOLDERS ON BUYING PROCESS FOR PERIODONTAL DISEASE TREATMENT
  • FIGURE 35 INFLUENCE OF STAKEHOLDERS ON BUYING PROCESS FOR PERIODONTAL DISEASE TREATMENT
  • FIGURE 36 PERIODONTAL DISEASE TREATMENT MARKET: INVESTMENT & FUNDING SCENARIO, 2021–2024
  • FIGURE 37 NORTH AMERICA: PERIODONTAL DISEASE TREATMENT MARKET SNAPSHOT
  • FIGURE 38 ASIA PACIFIC: PERIODONTAL DISEASE TREATMENT MARKET SNAPSHOT
  • FIGURE 39 OVERVIEW OF STRATEGIES DEPLOYED BY KEY MANUFACTURING COMPANIES
  • FIGURE 40 REVENUE ANALYSIS OF KEY PLAYERS IN PERIODONTAL DISEASE TREATMENT MARKET (2019–2023)
  • FIGURE 41 MARKET SHARE ANALYSIS OF KEY PLAYERS IN PERIODONTAL DISEASE TREATMENT MARKET (2023)
  • FIGURE 42 PERIODONTAL DISEASE TREATMENT MARKET: COMPANY EVALUATION MATRIX (KEY PLAYERS), 2023
  • FIGURE 43 PERIODONTAL DISEASE TREATMENT MARKET: COMPANY FOOTPRINT
  • FIGURE 44 PERIODONTAL DISEASE TREATMENT MARKET: COMPANY EVALUATION MATRIX (STARTUPS/SMES), 2023
  • FIGURE 45 EV/EBITDA OF KEY VENDORS
  • FIGURE 46 YEAR-TO-DATE (YTD) PRICE TOTAL RETURN AND 5-YEAR STOCK BETA OF KEY VENDORS
  • FIGURE 47 PERIODONTAL DISEASE TREATMENT MARKET: BRAND/PRODUCT COMPARATIVE ANALYSIS, BY MODEL
  • FIGURE 48 R&D EXPENDITURE OF KEY PLAYERS IN PERIODONTAL DISEASE TREATMENT MARKET (2022 VS. 2023)
  • FIGURE 49 DENTSPLY SIRONA: COMPANY SNAPSHOT (2023)
  • FIGURE 50 ENVISTA HOLDINGS CORPORATION: COMPANY SNAPSHOT (2023)
  • FIGURE 51 INSTITUT STRAUMANN AG: COMPANY SNAPSHOT (2023)
  • FIGURE 52 HENRY SCHEIN, INC.: COMPANY SNAPSHOT (2023)
  • FIGURE 53 BIOLASE INC.: COMPANY SNAPSHOT (2023)
  • FIGURE 54 NAKANISHI INC.: COMPANY SNAPSHOT (2023)

 

This study involved the extensive use of both primary and secondary sources. The research process involved the study of various factors affecting the industry to identify the segmentation types, industry trends, key players, competitive landscape, fundamental market dynamics, and key player strategies.

Secondary Research

The secondary research process involves the widespread use of secondary sources, directories, databases (such as Bloomberg Businessweek, Factiva, and D&B Hoovers), white papers, annual reports, company house documents, investor presentations, SEC filings of companies and publications from government sources [such as National Institutes of Health (NIH), US FDA, US Census Bureau, World Health Organization (WHO), International Trade Administration (ITA), Global Burden of Disease Study , International Diabetes Federation (IDF), and Centers for Medicare and Medicaid Services (CMS) were referred to identify and collect information for the global periodontal disease treatment market study. It was also used to obtain important information about the key players and market classification & segmentation according to industry trends to the bottom-most level and key developments related to market and technology perspectives. A database of the key industry leaders was also prepared using secondary research.

Primary Research

In the primary research process, various sources from both the supply and demand sides were interviewed to obtain qualitative and quantitative information for this report. The primary sources from the supply side include industry experts such as CEOs, vice presidents, marketing and sales directors, technology & innovation directors, and related key executives from various key companies and organizations in the periodontal disease treatment market. The primary sources from the demand side include pharmaceutical, biopharmaceutical companies, contract development and manufacturing organizations, and research academics and universities. Primary research was conducted to validate the market segmentation, identify key players in the market, and gather insights on key industry trends & key market dynamics.

A breakdown of the primary respondents is provided below:

*C-level primaries include CEOs, CFOs, COOs, and VPs.

*Others include sales managers, marketing managers, business development managers, product managers, distributors, and suppliers.

Note: Companies are classified into tiers based on their total revenue. As of 2023, Tier 1 = >USD 10.00 billion, Tier 2 = USD 1.00 billion to USD 10.00 billion, and Tier 3 = < USD 1.00 billion.

Source: MarketsandMarkets Analysis

To know about the assumptions considered for the study, download the pdf brochure

Market Size Estimation

For the global market value, annual revenues were calculated based on the revenue mapping of major product manufacturers and OEMs active in the global periodontal disease treatment market. All the major product manufacturers were identified at the global and/or country/regional level. Revenue mapping for the respective business segments/sub-segments was done for the major players. Also, the global periodontal disease treatment market was split into various segments and sub-segments based on:

  • List of major players operating in the products market at the regional and/or country level
  • Product mapping of various periodontal disease treatment manufacturers at the regional and/or country level
  • Mapping of annual revenue generated by listed major players from pain management devices(or the nearest reported business unit/product category)
  • Revenue mapping of major players to cover at least 70-75% of the global market share as of 2023
  • Extrapolation of the revenue mapping of the listed major players to derive the global market value of the respective segments/subsegments
  • Summation of the market value of all segments/subsegments to arrive at the global point-of-care  diagnostics market

The above-mentioned data was consolidated and added with detailed inputs and analysis from MarketsandMarkets and presented in this report.

Data Triangulation

After arriving at the overall size of the global periodontal disease treatment market through the above-mentioned methodology, this market was split into several segments and subsegments. The data triangulation and market breakdown procedures were employed, wherever applicable, to complete the overall market engineering process and arrive at the exact market value data for the key segments and subsegments. The extrapolated market data was triangulated by studying various macro indicators and regional trends from both demand- and supply-side participants.

Market Definition

Periodontal disease treatment refers to the medical interventions aimed at preventing, controlling, and treating the inflammation and damage caused by infections of the structures around the teeth, including the gums, periodontal ligament, and alveolar bone. Treatments typically range from non-surgical methods such as scaling and root planing (deep cleaning) to surgical procedures like flap surgery or bone grafting, depending on the severity of the disease. The goal is to eliminate the bacterial infection and halt the progression of the disease, thereby preserving the teeth and surrounding tissues.

Stakeholders

  • Manufacturers and distributors of medical devices
  • Periodontal Disease Treatment manufacturers
  • Contract manufacturers of dental equipment
  • Distributors of dental equipment
  • Research and consulting firms
  • Raw material suppliers of Periodontal Disease Treatment
  • Dental hospitals and clinics
  • Dental laboratories and associations
  • Dental practitioners
  • Dental laboratory technicians
  • Healthcare institutions
  • Diagnostic laboratories
  • Hospitals and clinics
  • Academic institutions
  • Research institutions
  • Government associations
  • Market research and consulting firms
  • Venture capitalists and investors

Report Objectives

  • To define, describe, and forecast the periodontal disease treatment market based on disease type, treatment type, end user, and region.
  • To forecast the market size based on five key regions: North America, Europe, Asia Pacific, Latin America, and Middle East & Africa.
  • To strategically analyze the industry trends, technology trends, pricing analysis, regulatory scenario, supply/value chain, ecosystem mapping, porter’s five forces, patent analysis, key stakeholders and buying criteria, and conference and events.
  • To provide detailed information regarding the major factors influencing the growth of this market (such as drivers, restraints, opportunities, and challenges)
  • To analyze the micromarkets with respect to individual growth trends, prospects, and contributions to the overall periodontal disease treatment market.
  • To analyze the opportunities for stakeholders and provide details of the competitive landscape for market leaders.
  • To strategically profile key players in the periodontal disease treatment market and comprehensively analyze their core competencies.
  • To track and analyze competitive developments such as product launches & approvals, partnerships, agreements, collaborations, joint ventures, expansions, and acquisitions in the overall periodontal disease treatment market.
  • To benchmark players within the market using the proprietary “Competitive Evaluation Matrix” framework, which analyzes market players on various parameters within the broad categories of business and product/service strategy
  • To analyze the generative AI  impact on the periodontal disease treatment market

Previous Versions of this Report

"Our USP is "providing game-changing business opportunities reports with free customization" - so please feel free to provide us with your specific areas of interest / business challenges in much greater detail !!"

We appreciate your interest in this report. Once you fill out the form, you'll be immediately directed to an exclusive solution tailored to your needs. This high-value offering can help boost your revenue by 30% - a must-see opportunity for anyone looking to maximize growth.


By clicking the "Submit" button, you are agreeing to the Terms of Use and Privacy Policy.

Custom Market Research Services

We Will Customise The Research For You, In Case The Report Listed Above Does Not Meet With Your Requirements

Get 10% Free Customisation

Growth opportunities and latent adjacency in Periodontal Disease Treatment Market

DMCA.com Protection Status